Financhill
Buy
71

CPIX Quote, Financials, Valuation and Earnings

Last price:
$2.27
Seasonality move :
-3.69%
Day range:
$2.25 - $2.39
52-week range:
$1.04 - $3.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.87x
P/B ratio:
1.29x
Volume:
187.9K
Avg. volume:
3.7M
1-year change:
31.03%
Market cap:
$32M
Revenue:
$39.6M
EPS (TTM):
-$0.77

Earnings Data

Next earnings date for CPIX
Mar 05
2025
Most recent earnings per share
-$0.11
Missed by $0.11
(Nov 7/2024)
Consensus Estimate
--
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CPIX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
11/07/2024 Q3 -- $9.1M -$0.11 -- --
08/06/2024 Q2 -- $9.8M -$0.08 -- --
05/07/2024 Q1 -- $8.5M -$0.14 -- --
03/05/2024 Q4 -- $9.4M -$0.44 -- --
11/07/2023 Q3 -- -- -$0.07 -- --
06/30/2023 Q2 -- -- $0.06 -- --
03/31/2023 Q1 -- -- $0.01 -- --
03/07/2023 Q4 -- -- -$0.17 -- --
11/08/2022 Q3 -- -- -$0.03 -- --
08/09/2022 Q2 -- -- -$0.09 -- --
05/10/2022 Q1 -- -- -$0.09 -- --
03/08/2022 Q4 -- -- -$0.26 -- --
11/09/2021 Q3 -- -- -$0.07 -- --
08/10/2021 Q2 -- -- $0.08 -$0.07 $0.15
05/11/2021 Q1 -- -- $0.01 -$0.07 $0.08
03/09/2021 Q4 -- -- -$0.06 -$0.01 -$0.05
11/10/2020 Q3 -- -- -$0.03 -$0.07 $0.04
08/11/2020 Q2 -- -- -$0.06 $0.03 -$0.09
05/20/2020 Q1 -- -- -$0.07 $0.02 -$0.09
03/18/2020 Q4 -- -- -$0.06 $0.01 -$0.07
11/12/2019 Q3 -- -- -$0.13 $0.11 -$0.24
08/14/2019 Q2 -- -- -$0.04 $0.07 -$0.11
05/14/2019 Q1 -- -- -- -$0.11 --
02/26/2019 Q4 -- -- -$0.14 -$0.16 $0.02
11/13/2018 Q3 -- -- -$0.11 -- --
08/14/2018 Q2 -- -- -$0.05 -- --
05/08/2018 Q1 -- -- -$0.15 -- --
03/06/2018 Q4 -- -- -$0.05 -- --
11/07/2017 Q3 -- -- -$0.05 -- --
08/08/2017 Q2 -- -- -$0.32 -- --
05/15/2017 Q1 -- -- -$0.08 -- --
03/07/2017 Q4 -- -- -$0.05 -- --
11/01/2016 Q3 -- -- $0.01 -- --
08/02/2016 Q2 -- -- -$0.00 -- --
05/10/2016 Q1 -- -- -$0.02 -- --
03/03/2016 Q4 -- -- $0.01 -- --
11/03/2015 Q3 -- -- $0.01 -- --
08/04/2015 Q2 -- -- $0.02 -- --
05/07/2015 Q1 -- -- $0.00 -- --
03/03/2015 Q4 -- -- $0.04 -- --

Cumberland Pharmaceuticals Earnings Questions

  • How Much did Cumberland Pharmaceuticals Generate in Revenue Last Quarter?

    Cumberland Pharmaceuticals reported $9.1M worth of top line sales in its most recent quarter.

  • Did Cumberland Pharmaceuticals Beat Earnings Last Quarter?

    Cumberland Pharmaceuticals announced earnings per share of -$0.11 which represents a miss of analyst forecast a -- per share.

  • Is Cumberland Pharmaceuticals Profitable?

    Cumberland Pharmaceuticals reported $7.8M that represents $0.55 per share over the last quarter.

  • What is the Analyst Consensus for Cumberland Pharmaceuticals EPS Next Year?

    Cumberland Pharmaceuticals's earnings are forecast to grow from -$0.44 per share to -- per share next year representing an increase of --.

  • When is Cumberland Pharmaceuticals's Earnings Date?

    Cumberland Pharmaceuticals's next earnings date is March 5, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.23% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 15.18% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.97% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock